Lacosamide-induced symptomatic sinus node dysfunction.

Shogo Minomo, Takeshi Amino, Nobuhiro Hara, Masahiko Ichijo, Toru Miyake, Asuka Yasuura, Tomoyuki Kamata
Author Information
  1. Shogo Minomo: Department of Neurology, Musashino Red Cross Hospital, 1-26-1, Kyonancho, Musashino-shi, Tokyo 1808610, Japan.
  2. Takeshi Amino: Department of Neurology, Musashino Red Cross Hospital, 1-26-1, Kyonancho, Musashino-shi, Tokyo 1808610, Japan.
  3. Nobuhiro Hara: Department of Cardiology, Musashino Red Cross Hospital, 1-26-1, Kyonancho, Musashino-shi, Tokyo 1808610, Japan.
  4. Masahiko Ichijo: Department of Neurology, Musashino Red Cross Hospital, 1-26-1, Kyonancho, Musashino-shi, Tokyo 1808610, Japan.
  5. Toru Miyake: Department of Neurology, Musashino Red Cross Hospital, 1-26-1, Kyonancho, Musashino-shi, Tokyo 1808610, Japan.
  6. Asuka Yasuura: Department of Neurology, Musashino Red Cross Hospital, 1-26-1, Kyonancho, Musashino-shi, Tokyo 1808610, Japan.
  7. Tomoyuki Kamata: Department of Neurology, Musashino Red Cross Hospital, 1-26-1, Kyonancho, Musashino-shi, Tokyo 1808610, Japan.

Abstract

No abstract text available.

MeSH Term

Humans
Lacosamide
Sick Sinus Syndrome

Chemicals

Lacosamide

Word Cloud

Created with Highcharts 10.0.0Lacosamide-inducedsymptomaticsinusnodedysfunction

Similar Articles

Cited By